MANAGED ACCOUNT ADVISORS LLC - IRONWOOD PHARMACEUTICALS INC ownership

IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 139 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is 0.53 and the average weighting 0.1%.

Quarter-by-quarter ownership
MANAGED ACCOUNT ADVISORS LLC ownership history of IRONWOOD PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2015$432,000
-37.6%
35,831
-17.1%
0.00%
-100.0%
Q1 2015$692,000
-3.9%
43,245
-8.0%
0.00%0.0%
Q4 2014$720,000
+24.8%
47,007
+5.6%
0.00%0.0%
Q3 2014$577,000
+60.7%
44,530
+90.4%
0.00%
Q2 2014$359,000
+72.6%
23,387
+38.5%
0.00%
Q1 2014$208,00016,8850.00%
Other shareholders
IRONWOOD PHARMACEUTICALS INC shareholders Q2 2015
NameSharesValueWeighting ↓
HealthInvest Partners AB 1,520,000$19,562,00018.54%
Sarissa Capital Management LP 16,390,000$210,939,00016.77%
Healthcare Value Capital, LLC 200,000$2,574,0005.13%
Camber Capital Management LP 7,500,000$96,525,0003.25%
13D Management LLC 650,455$8,371,0002.88%
BRIDGER MANAGEMENT, LLC 2,035,114$26,192,0002.44%
Brown Capital Management 18,484,759$237,899,0001.80%
Healthcare Value Capital, LLC 50,000$644,0001.28%
Zebra Capital Management LLC 53,359$687,0000.80%
PRICE MICHAEL F 520,000$6,692,0000.74%
View complete list of IRONWOOD PHARMACEUTICALS INC shareholders